Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Penetrance of different cancer types in families with Li-Fraumeni syndrome: a validation study using multi-center cohorts.

Shin SJ, Dodd-Eaton EB, Peng G, Bojadzieva J, Chen J, Amos CI, Frone MN, Khincha P, Mai PL, Savage SA, Ballinger ML, Thomas DM, Yuan Y, Strong LC, Wang W.

Cancer Res. 2019 Nov 12. pii: canres.0728.2019. doi: 10.1158/0008-5472.CAN-19-0728. [Epub ahead of print]

PMID:
31719101
2.

Family Health Leaders: Lessons on Living with Li-Fraumeni Syndrome across Generations.

Pantaleao A, Young JL, Epstein NB, Carlson M, Bremer RC, Khincha PP, Peters JA, Greene MH, Roy K, Achatz MI, Savage SA, Werner-Lin A.

Fam Process. 2019 Oct 24. doi: 10.1111/famp.12497. [Epub ahead of print]

PMID:
31647118
3.

An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Niewisch MR, Savage SA.

Expert Rev Hematol. 2019 Sep 10:1-16. doi: 10.1080/17474086.2019.1662720. [Epub ahead of print]

PMID:
31478401
4.

Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.

Wang Y, McReynolds LJ, Dagnall C, Katki HA, Spellman SR, Wang T, Hicks B, Freedman ND, Jones K, Lee SJ, Savage SA, Gadalla SM.

Br J Haematol. 2019 Aug 19. doi: 10.1111/bjh.16153. [Epub ahead of print]

PMID:
31426123
5.

The Utility of Rivaroxaban as Primary Venous Thromboprophylaxis in an Adult Trauma Population.

Kingdon LK, Miller EM, Savage SA.

J Surg Res. 2019 Dec;244:509-515. doi: 10.1016/j.jss.2019.06.079. Epub 2019 Jul 20.

PMID:
31336243
6.

Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth.

Wang Y, Brummel SS, Beilstein-Wedel E, Dagnall CL, Hazra R, Kacanek D, Chadwick EG, Marsit CJ, Chanock SJ, Savage SA, Poirier MC, Machiela MJ, Engels EA; Pediatric HIV/AIDS Cohort Study.

AIDS. 2019 Nov 1;33(13):2091-2096. doi: 10.1097/QAD.0000000000002317.

PMID:
31335808
7.

Measuring awareness in people with dementia: protocol for a scoping review.

Alexander CM, Martyr A, Savage SA, Clare L.

Syst Rev. 2019 Jul 4;8(1):160. doi: 10.1186/s13643-019-1078-5.

8.

Reproductive factors associated with breast cancer risk in Li-Fraumeni syndrome.

Khincha PP, Best AF, Fraumeni JF Jr, Loud JT, Savage SA, Achatz MI.

Eur J Cancer. 2019 Jul;116:199-206. doi: 10.1016/j.ejca.2019.05.005. Epub 2019 Jun 15.

PMID:
31212162
9.

Utilizing Native Directing Groups: Mechanistic Understanding of a Direct Arylation Leads to Formation of Tetracyclic Heterocycles via Tandem Intermolecular, Intramolecular C-H Activation.

Wisniewski SR, Savage SA, Romero EO, Eastgate MD, Tan Y, Simmons EM, Plata RE, Sowa JR Jr, Blackmond DG.

J Org Chem. 2019 Jun 21;84(12):7961-7970. doi: 10.1021/acs.joc.9b00823. Epub 2019 Jun 4.

PMID:
31117568
10.

Response to: Concern regarding classification of germlineTP53 variants as likely pathogenic.

de Andrade KC, Frone MN, Wegman-Ostrosky T, Khincha PP, Kim J, Amadou A, Santiago KM, Fortes FP, Lemonnier N, Mirabello L, Stewart DR, Hainaut P, Kowalski LP, Savage SA, Achatz MI.

Hum Mutat. 2019 Jun;40(6):832-833. doi: 10.1002/humu.23749. Epub 2019 Apr 18. No abstract available.

PMID:
30997946
11.

Inequality in the Survival of Patients With Head and Neck Cancer in Scotland.

Ingarfield K, McMahon AD, Douglas CM, Savage SA, MacKenzie K, Conway DI.

Front Oncol. 2019 Jan 22;8:673. doi: 10.3389/fonc.2018.00673. eCollection 2018.

12.

NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia.

Savage SA, Irani SR, Leite MI, Zeman AZ.

J Neuroimmunol. 2019 Feb 15;327:41-43. doi: 10.1016/j.jneuroim.2019.01.011. Epub 2019 Jan 22.

13.

Determinants of long-term survival in a population-based cohort study of patients with head and neck cancer from Scotland.

Ingarfield K, McMahon AD, Douglas CM, Savage SA, Conway DI, MacKenzie K.

Head Neck. 2019 Jun;41(6):1908-1917. doi: 10.1002/hed.25630. Epub 2019 Jan 8.

PMID:
30620423
14.

The EGS grading scale for skin and soft-tissue infections is predictive of poor outcomes: a multicenter validation study.

Savage SA, Li SW, Utter GH, Cox JA, Wydo SM, Cahill K, Sarani B, Holzmacher J, Duane TM, Gandhi RR, Zielinski MD, Ray-Zack M, Tierney J, Chapin T, Murphy PB, Vogt KN, Schroeppel TJ, Callaghan E, Kobayashi L, Coimbra R, Schuster KM, Gillaspie D, Timsina L, Louis A, Crandall M.

J Trauma Acute Care Surg. 2019 Apr;86(4):601-608. doi: 10.1097/TA.0000000000002175.

PMID:
30601458
15.

Couples coping with screening burden and diagnostic uncertainty in Li-Fraumeni syndrome: Connection versus independence.

Young JL, Pantaleao A, Zaspel L, Bayer J, Peters JA, Khincha PP, Bremer RC, Loud JT, Greene MH, Achatz MI, Savage SA, Werner-Lin A.

J Psychosoc Oncol. 2019 Mar-Apr;37(2):178-193. doi: 10.1080/07347332.2018.1543376. Epub 2018 Dec 28.

16.

Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.

Kim J, Luo W, Wang M, Wegman-Ostrosky T, Frone MN, Johnston JJ, Nickerson ML, Rotunno M, Li SA, Achatz MI, Brodie SA, Dean M, de Andrade KC, Fortes FP, Gianferante M, Khincha P, McMaster ML, McReynolds LJ, Pemov A, Pinheiro M, Santiago KM, Alter BP, Caporaso NE, Gadalla SM, Goldin LR, Greene MH, Loud J, Yang XR, Freedman ND, Gapstur SM, Gaudet MM, Calista D, Ghiorzo P, Fargnoli MC, Nagore E, Peris K, Puig S, Landi MT, Hicks B, Zhu B, Liu J, Sampson JN, Chanock SJ, Mirabello LJ, Morton LM, Biesecker LG, Tucker MA, Savage SA, Goldstein AM, Stewart DR.

Genome Med. 2018 Dec 24;10(1):99. doi: 10.1186/s13073-018-0607-5.

17.

Utilizing Native Directing Groups: Synthesis of a Selective IKur Inhibitor, BMS-919373, via a Regioselective C-H Arylation.

Wisniewski SR, Stevens JM, Yu M, Fraunhoffer KJ, Romero EO, Savage SA.

J Org Chem. 2019 Apr 19;84(8):4704-4714. doi: 10.1021/acs.joc.8b02254. Epub 2018 Nov 15.

PMID:
30395712
18.

Telomere Length Calibration from qPCR Measurement: Limitations of Current Method.

Wang Y, Savage SA, Alsaggaf R, Aubert G, Dagnall CL, Spellman SR, Lee SJ, Hicks B, Jones K, Katki HA, Gadalla SM.

Cells. 2018 Oct 24;7(11). pii: E183. doi: 10.3390/cells7110183.

19.

Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.

de Andrade KC, Frone MN, Wegman-Ostrosky T, Khincha PP, Kim J, Amadou A, Santiago KM, Fortes FP, Lemonnier N, Mirabello L, Stewart DR, Hainaut P, Kowalski LP, Savage SA, Achatz MI.

Hum Mutat. 2019 Jan;40(1):97-105. doi: 10.1002/humu.23673. Epub 2018 Nov 19.

PMID:
30352134
20.

Understanding the evolving phenotype of vascular complications in telomere biology disorders.

Higgs C, Crow YJ, Adams DM, Chang E, Hayes D Jr, Herbig U, Huang JN, Himes R, Jajoo K, Johnson FB, Reynolds SD, Yonekawa Y, Armanios M, Boulad F, DiNardo CD, Dufour C, Goldman FD, Khan S, Kratz C, Myers KC, Raghu G, Alter BP, Aubert G, Bhala S, Cowen EW, Dror Y, El-Youssef M, Friedman B, Giri N, Helms Guba L, Khincha PP, Lin TF, Longhurst H, McReynolds LJ, Nelson A, Olson T, Pariser A, Perona R, Sasa G, Schratz K, Simonetto DA, Townsley D, Walsh M, Stevens K, Agarwal S, Bertuch AA, Savage SA; Clinical Care Consortium for Telomere-associated Ailments (CCCTAA).

Angiogenesis. 2019 Feb;22(1):95-102. doi: 10.1007/s10456-018-9640-7. Epub 2018 Aug 25.

PMID:
30168024
21.

Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.

Savage SA, Walsh MF.

Hematol Oncol Clin North Am. 2018 Aug;32(4):657-668. doi: 10.1016/j.hoc.2018.04.002. Review.

22.

Mouse Homolog of the Human TP53 R337H Mutation Reveals Its Role in Tumorigenesis.

Park JH, Li J, Starost MF, Liu C, Zhuang J, Chen J, Achatz MI, Kang JG, Wang PY, Savage SA, Hwang PM.

Cancer Res. 2018 Sep 15;78(18):5375-5383. doi: 10.1158/0008-5472.CAN-18-0016. Epub 2018 Jul 24.

23.

Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia.

Wang Y, Zhou W, Alter BP, Wang T, Spellman SR, Haagenson M, Yeager M, Lee SJ, Chanock SJ, Savage SA, Gadalla SM.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2003-2008. doi: 10.1016/j.bbmt.2018.05.027. Epub 2018 Jun 4.

24.

Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Khincha PP, Bertuch AA, Gadalla SM, Giri N, Alter BP, Savage SA.

Blood Adv. 2018 Jun 12;2(11):1243-1249. doi: 10.1182/bloodadvances.2018016964.

25.

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54].

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HBA, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2018 Sep;74(3):e85-e86. doi: 10.1016/j.eururo.2018.05.017. Epub 2018 May 28. No abstract available.

PMID:
29853305
26.

Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.

Ratnasamy V, Navaneethakrishnan S, Sirisena ND, Grüning NM, Brandau O, Thirunavukarasu K, Dagnall CL, McReynolds LJ, Savage SA, Dissanayake VHW.

BMC Med Genet. 2018 May 25;19(1):85. doi: 10.1186/s12881-018-0584-y.

27.

Beginning at the ends: telomeres and human disease.

Savage SA.

F1000Res. 2018 May 1;7. pii: F1000 Faculty Rev-524. doi: 10.12688/f1000research.14068.1. eCollection 2018. Review.

28.

Complex phenotype of dyskeratosis congenita and mood dysregulation with novel homozygous RTEL1 and TPH1 variants.

Ungar RA, Giri N, Pao M, Khincha PP, Zhou W, Alter BP, Savage SA.

Am J Med Genet A. 2018 Jun;176(6):1432-1437. doi: 10.1002/ajmg.a.38706. Epub 2018 Apr 25.

29.

Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.

McMaster ML, Sun C, Landi MT, Savage SA, Rotunno M, Yang XR, Jones K, Vogt A, Hutchinson A, Zhu B, Wang M, Hicks B, Thirunavukarason A, Stewart DR, Koutros S, Goldstein AM, Chanock SJ, Caporaso NE, Tucker MA, Goldin LR, Liu Y.

Br J Haematol. 2018 May;181(3):372-377. doi: 10.1111/bjh.15203.

30.

Relationship between plasma 25-hydroxymitamin D and leucocyte telomere length by sex and race in a US study - CORRIGENDUM.

Liu JJ, Cahoon EK, Linet MS, Little MP, Dagnall CL, Higson H, Savage SA, Freedman DM.

Br J Nutr. 2018 Apr;119(8):966. doi: 10.1017/S0007114518000478. No abstract available.

PMID:
29644955
31.

Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.

Gadalla SM, Aubert G, Wang T, Haagenson M, Spellman SR, Wang L, Katki HA, Savage SA, Lee SJ.

Blood. 2018 May 24;131(21):2393-2398. doi: 10.1182/blood-2017-10-812735. Epub 2018 Apr 9.

32.

The Alvarado score should be used to reduce emergency department length of stay and radiation exposure in select patients with abdominal pain.

Coleman JJ, Carr BW, Rogers T, Field MS, Zarzaur BL, Savage SA, Hammer PM, Brewer BL, Feliciano DV, Rozycki GS.

J Trauma Acute Care Surg. 2018 Jun;84(6):946-950. doi: 10.1097/TA.0000000000001885.

PMID:
29521805
33.

Shock volume: Patient-specific cumulative hypoperfusion predicts organ dysfunction in a prospective cohort of multiply injured patients.

McKinley TO, McCarroll T, Metzger C, Zarzaur BL, Savage SA, Bell TM, Gaski GE.

J Trauma Acute Care Surg. 2018 Jul;85(1S Suppl 2):S84-S91. doi: 10.1097/TA.0000000000001871.

34.

No association between donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia.

Gadalla SM, Wang T, Loftus D, Friedman L, Dagnall C, Haagenson M, Spellman SR, Buturovic L, Blauwkamp M, Shelton J, Fleischhauer K, Hsu KC, Verneris MR, Krstajic D, Hicks B, Jones K, Lee SJ, Savage SA.

Bone Marrow Transplant. 2018 Apr;53(4):383-391. doi: 10.1038/s41409-017-0029-9. Epub 2017 Dec 21.

35.

Presenting symptoms and long-term survival in head and neck cancer.

Douglas CM, Ingarfield K, McMahon AD, Savage SA, Conway DI, MacKenzie K.

Clin Otolaryngol. 2018 Jun;43(3):795-804. doi: 10.1111/coa.13053. Epub 2018 Jan 15.

PMID:
29247495
36.

Pediatric leukemia susceptibility disorders: manifestations and management.

McReynolds LJ, Savage SA.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):242-250. doi: 10.1182/asheducation-2017.1.242. Review.

37.

Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients.

Koster R, Panagiotou OA, Wheeler WA, Karlins E, Gastier-Foster JM, Caminada de Toledo SR, Petrilli AS, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Lecanda F, Serra M, Hattinger C, Picci P, Scotlandi K, Thomas DM, Ballinger ML, Gorlick R, Barkauskas DA, Spector LG, Tucker M, Belynda DH, Yeager M, Hoover RN, Wacholder S, Chanock SJ, Savage SA, Mirabello L.

Int J Cancer. 2018 Apr 15;142(8):1594-1601. doi: 10.1002/ijc.31195. Epub 2017 Dec 23.

38.

Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.

Alter BP, Giri N, Savage SA, Rosenberg PS.

Haematologica. 2018 Jan;103(1):30-39. doi: 10.3324/haematol.2017.178111. Epub 2017 Oct 19.

39.

Beyond the triad: Inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita.

Ward SC, Savage SA, Giri N, Alter BP, Rosenberg PS, Pichard DC, Cowen EW.

J Am Acad Dermatol. 2018 Apr;78(4):804-806. doi: 10.1016/j.jaad.2017.10.017. Epub 2017 Oct 16. No abstract available.

40.

Progressive reticulate skin pigmentation and anonychia in a patient with bone marrow failure.

Ward SC, Savage SA, Giri N, Alter BP, Cowen EW.

J Am Acad Dermatol. 2017 Dec;77(6):1194-1198. doi: 10.1016/j.jaad.2017.07.018. Epub 2017 Oct 21.

41.

Clot dynamics and mortality: The MA-R ratio.

Savage SA, Zarzaur BL, Pohlman TH, Brewer BL, Magnotti LJ, Croce MA, Lim GH, Martin AC.

J Trauma Acute Care Surg. 2017 Oct;83(4):628-634. doi: 10.1097/TA.0000000000001637.

PMID:
28930957
42.

Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement.

Dagnall CL, Hicks B, Teshome K, Hutchinson AA, Gadalla SM, Khincha PP, Yeager M, Savage SA.

PLoS One. 2017 Sep 8;12(9):e0184098. doi: 10.1371/journal.pone.0184098. eCollection 2017.

43.

Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history.

de Andrade KC, Mirabello L, Stewart DR, Karlins E, Koster R, Wang M, Gapstur SM, Gaudet MM, Freedman ND, Landi MT, Lemonnier N, Hainaut P, Savage SA, Achatz MI.

Hum Mutat. 2017 Dec;38(12):1723-1730. doi: 10.1002/humu.23320. Epub 2017 Sep 21.

44.

Pregnancies in patients with inherited bone marrow failure syndromes in the NCI cohort.

Giri N, Stratton P, Savage SA, Alter BP.

Blood. 2017 Oct 5;130(14):1674-1676. doi: 10.1182/blood-2017-08-802991. Epub 2017 Aug 24. No abstract available.

45.

Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives.

Khincha PP, Dagnall CL, Hicks B, Jones K, Aviv A, Kimura M, Katki H, Aubert G, Giri N, Alter BP, Savage SA, Gadalla SM.

Int J Mol Sci. 2017 Aug 13;18(8). pii: E1765. doi: 10.3390/ijms18081765.

46.

Pregnancy outcomes in mothers of offspring with inherited bone marrow failure syndromes.

Giri N, Reed HD, Stratton P, Savage SA, Alter BP.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26757. Epub 2017 Aug 12.

PMID:
28801981
47.

Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HB, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2017 Nov;72(5):747-754. doi: 10.1016/j.eururo.2017.07.015. Epub 2017 Aug 7. Erratum in: Eur Urol. 2018 May 28;:.

48.

Bone cancer: Is the osteosarcoma genome targetable?

Savage SA, Mirabello L.

Nat Rev Endocrinol. 2017 Sep;13(9):506-508. doi: 10.1038/nrendo.2017.101. Epub 2017 Aug 4. No abstract available.

PMID:
28776583
49.

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.

Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, Achatz MI, Chojniak R, Balieiro da Costa A, Santiago KM, Garber J, O'Neill AF, Eeles RA, Evans DG, Bleiker E, Sonke GS, Ruijs M, Loo C, Schiffman J, Naumer A, Kohlmann W, Strong LC, Bojadzieva J, Malkin D, Rednam SP, Stoffel EM, Koeppe E, Weitzel JN, Slavin TP, Nehoray B, Robson M, Walsh M, Manelli L, Villani A, Thomas DM, Savage SA.

JAMA Oncol. 2017 Dec 1;3(12):1634-1639. doi: 10.1001/jamaoncol.2017.1968. Erratum in: JAMA Oncol. 2018 Apr 1;4(4):590.

50.

Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.

Mai PL, Khincha PP, Loud JT, DeCastro RM, Bremer RC, Peters JA, Liu CY, Bluemke DA, Malayeri AA, Savage SA.

JAMA Oncol. 2017 Dec 1;3(12):1640-1645. doi: 10.1001/jamaoncol.2017.1350.

Supplemental Content

Loading ...
Support Center